| Objective:To explore the clinical effect of transurethral plasmakinetic resection in the treatment of benign prostatic hyperplasia.Methods:Selected 64 cases of benign prostatic hyperplasia patients who doctored in our hospital from January 2013 to 2014, it
was randomly divided into PKRP group and TURP group, 32 cases in each group. Group PKRP patients used transurethral plasmakinetic
resection of prostate for treatment, patients in TURP group with transurethral resection of the prostate for treatment. Comparison of two
groups patients postoperation curative effect index, and recorded the complications.Results:Compared with the TURP group, operation
time of PKRP group significantly increased, the amount of bleeding significantly reduced, indwelling catheter time and hospitalization
shortened significantly, gland excision increased, the differences was statistically significant (P<0.05). After operation, the IPSS, QOL,
RUV and Qmax significantly improved when compared with before (P<0.05), and PKRP group was significantly lower than that of
TURP group, while Qmax was higher than that in group TURP (P<0.05). Adverse reactions of the two groups including transurethral resection
syndrome, temporary incontinence, delayed hemorrhage and urethral stricture, the total incidence rate in PKRP group was significantly
lower than that in TURP group, the difference was statistically significant (P<0.05).Conclusion:The clinical effect of PKRP in the
treatment of benign prostatic hyperplasia is better than TURP and it is worthy of clinical rational use. |
